Sherman, RE, Anderson, SA, Dal Pan, GJ, et al.
Real-world evidence — What is it and what can it tell us?
N Engl J Med. 2016;375:2293–2297.
White, R. Building trust in real-world evidence and comparative effectiveness research: The need for transparency. J Comp Eff Res. 2017; 6:5–7.
Garrison, LP Jr, PJ, Neumann, Erickson, P, Marshall, D, Mullins, CD. Using real-world data for coverage and payment decisions: The ISPOR Real-World Data Task Force report. Value Health. 2007;10:326–335.
Collins, FS, Varmus, H. A new initiative on precision medicine. N Engl J Med. 2015;372:793–795.
PCORnet, the National Patient-Centered Clinical Research Network. October 19, 2017. [Internet]. http://www.pcornet.org/. (accessed November 13, 2017).
Gibson, TB, Ehrlich, ED, Graff, J, et al.
Real-world impact of comparative effectiveness research findings on clinical practice. Am J Manag Care. 2014;20:e208–e220.
Ioannidis, J, Haidich, A, Pappa, M, et al.
Comparison of evidence of treatment effects in randomized and nonrandomized studies. JAMA. 2001;286:821–829.
Concato, J, Shah, N, Horwitz, RI. Randomized, controlled trials, observational studies, and the hierarchy of research designs. N Engl J Med. 2000;342:1887–1892.
MacLehose, RR, Reeves, BC, Harvey, IM, Sheldon, TA, Russell, IT, Black, AM. A systematic review of comparisons of effect sizes derived from randomised and non-randomised studies. Health Technol Assess. 2000;4:1–154.
Anglemyer, A, Horvath, HT, Bero, L. Healthcare outcomes assessed with observational study designs compared with those assessed in randomized trials. Cochrane Database Syst Rev. 2014;4:MR000034.
Starks, H, Diehr, P, Curtis, J. The challenge of selection bias and confounding in palliative care research. Journal of Palliative Medicine. 2009;12:181–187.
Greenfield, S, Kaplan, SH. Building useful evidence: Changing the clinical research paradigm to account for comparative effectiveness research. J Comp Eff Res. 2012;1:263–270.
Villas Boas, PJ, Spagnuolo, RS, Kamegasawa, A, et al.
Systematic reviews showed insufficient evidence for clinical practice in 2004: What about in 2011? The next appeal for the evidence-based medicine age. J Eval Clin Pract. 2013;19:633–637.
Wager, E, Williams,
Overcome failure to Publish nEgative fiNdings Consortium. “Hardly worth the effort”? Medical journals' policies and their editors' and publishers' views on trial registration and publication bias: Quantitative and qualitative study. BMJ. 2013;347:f5248.
Cals, JW, Mallen, CD, Glynn, LG, Kotz, D. Should authors submit previous peer-review reports when submitting research papers? Views of general medical journal editors. Ann Fam Med. 2013;11:179–181.
Hing, CB, Higgs, D, Hooper, L, Donell, ST, Song, F. A survey of orthopaedic journal editors determining the criteria of manuscript selection for publication. J Orthop Surg Res. 2011;6:19.
Pouwels, KB, Widyakusuma, NN, Groenwold, RH, Hak, E. Quality of reporting of confounding remained suboptimal after the STROBE guideline. J Clin Epidemiol. 2016;69:217–224.
Price, D, Bateman, ED, Chisholm, A, et al.
Complementing the randomized controlled trial evidence base. Evolution not revolution. Ann Am Thorac Surg. 2014;11:S92–S98.
Editors. The registration of observational studies–When metaphors go bad. Epidemiology. 2010;21:607–609.
Kreis, J, Panteli, D, Busse, R. How health technology assessment agencies address the issue of unpublished data. Int J Technol Assess Health Care. 2014;30:34–43.
Sabharwal, RK, Graff, JS, Holve, E, Dubois, RW. Developing evidence that is fit for purpose: A framework for payer and research dialogue. Am J Manag Care. 2015;21:e545–e551.
Mullins, CD, Abdulhalim, AM, Lavallee, DC. Continuous patient engagement in comparative effectiveness research. JAMA. 2012;307:1587–1588.
Perfetto, EM, Burke, L, Oehrlein, EM, Epstein, RS. Patient-focused drug development: A new direction for collaboration. Med Care. 2015;53:9–17.
Schroter, S, Black, N, Evans, S, Godlee, F, Osorio, L, Smith, R. What errors do peer reviewers detect, and does training improve their ability to detect them?
J R Soc Med. 2008;101:507–514.
Haug, CJ. Peer-review fraud — Hacking the scientific publication process. N Engl J Med. 2015;373:2393–2395.
Sorokowski, P, Kulczycki, E, Sorokowska, A, Pisanski, K. Predatory journals recruit fake editor. Nature. 2017;543:481–483.
EASE Guidelines for Authors and Translators of Scientific Articles to be Published in English. Acta Inform Med. 2014;22:210–217.
Perfetto, EM, Anyanwu, C, Pickering, MK, Zaghab, RW, Graff, JS, Eichelberger, B. Got CER? Educating pharmacists for practice in the future: New tools for new challenges. J Manag Care Spec Pharm. 2016;22:609–616.
MacMahon, B, Weiss, NS. Is there a dark phase of this STROBE?
Shattell, MM, Chinn, P, Thomas, SP, Cowling, WR III. Authors' and editors' perspectives on peer review quality in three scholarly nursing journals. J Nurs Scholarsh. 2010;42:58–65.
Weber, EJ, Katz, PP, Waeckerle, JF, Callaham, ML. Author perception of peer review: Impact of review quality and acceptance on satisfaction. JAMA. 2002;287:2790–2793.
Academy of Managed Care Pharmacy. The AMCP Format for Formulary Submissions Version 4.0. April 21, 2016. [Internet]. http://www.amcp.org/FormatV4/. (accessed November 13, 2017).
Weissman, JS, Westrich, K, Hargraves, JL, et al.
Translating comparative effectiveness research into Medicaid payment policy: Views from medical and pharmacy directors. J Comp Eff Res. 2015;4: 79–88.
Hurwitz, JT, Brown, M, Graff, JS, Peters, L, Malone, DC. Is real-world evidence used in P&T monographs and therapeutic class reviews?
J Manag Care Spec Pharm. 2017;23:613–620.
Rangarao Peck, S, Kleiner, H, Graff, JS, Lustig, A, Dubois, RW, Wallace, P. Are clinical practice guidelines being informed by real-world data?
BMC Health Serv Res. In press.
Schnipper, LE, Davidson, NE, Wollins, DS, et al.
American Society of Clinical Oncology Statement: A conceptual framework to assess the value of cancer treatment options. J Clin Oncol. 2015;33:2563–2577.
Makady, A, Ham, RT, de Boer, A, et al.
Policies for use of real-world data in health technology assessment (HTA): A comparative study of six HTA agencies. Value Health. 2017;20:520–532.